ISMMS CTSA, ConduITS Evaluation and Continuous Improvement (ECI) Core

Sep 30, 2020 | Conduits News

The mission of the ISMMS CTSA, ConduITS, is to streamline and centralize the infrastructure needed to accelerate translational research across an ever expanding research enterprise; foster team science responsive to emerging theories, technologies, and data science challenges; innovate processes to increase the quality and efficiency of translational research; develop informatics tools and solutions to accelerate the full translational continuum; and develop innovative educational programs training the workforce needed to respond to the challenges of 21st Century translational science.

In order to maximize the CTSA Program consortium’s impact, NCATS has implemented the Common Metrics Initiative (CMI). The CMI is based on the principles of the Results-Based Accountability (RBA) framework and is a collaborative process with the CTSA Program hubs used to develop, implement and report on specific metrics that are common across the consortium. The vision for NCATS’ CMI is to use specific, common metrics to demonstrate and improve the impact of the CTSA Program. The CMI uses this set of metrics to help focus network and hub activities on making significant, measurable improvements in translational science and research, and workforce development.

The Evaluation and Continuous Improvement (ECI) core at Mount Sinai, led by Brian Nickerson, PhD and Layla Fattah, MEd, was implemented to create an overall strategy for evaluation across the ConduITS cores. The ECI team engages with a mix of stakeholders to advance the development and implementation of innovative solutions to meet the strategic goals of our CTSA grant. Pursuant to this role, the ECI team collaborates with ConduITS leaders by utilizing evaluation activities and methods that range from fundamental assessment techniques to emerging cutting-edge methods and metrics. As internal evaluators, the team works across the Cores to develop relevant and useful metrics for examining innovation impact and continuous improvement activities. In addition, the ECI is uniquely situated to interpret and connect the national CTSA common metrics locally in efforts towards improvement and innovation.

ConduITS is supported by NCATS of the NIH’s CTSA Program. Any use of CTSA-supported resources requires citation of grant number UL1TR001433 awarded to ISMMS in the acknowledgment section of every publication resulting from this support. Adherence to the NIH Public Access Policy is also required.

 

 

Recent ConduITS News

What does the Innovation Core do?

Mount Sinai’s Innovation Core is designed to fill the gap in the training and expertise needed to move a discovery from the research setting into a commercially viable product, or to recognize the potential for commercialization. i3 Prism i3 Prism is an early-stage...

read more

What is the Innovation Core?

Mount Sinai’s Innovation Partners (MSIP) is the technology commercialization arm of the Mount Sinai Health System, responsible for driving the real-world application of Mount Sinai discoveries and inventions, and the development of research partnerships with industry....

read more

Newsletter Special Edition

Click here to view the special edition of the Conduit Newsletter, designed in CANVA! As part of a new initiative by The Mount Sinai ConduITS Institutes for Translational Sciences (CTSA), we are thrilled to introduce our latest newsletter designed to aid researchers in...

read more

Trainee Corner

Mount Sinai CTSA Featured Trainees

Megan Januska

Megan Januska

Megan Januska, MD is an Assistant Professor in the Division of Pediatric Pulmonology in the Jack and Lucy Clark Department of Pediatrics and in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai and Mount Sinai Kravis...

read more
Sangeetha Vadakke-Madathil

Sangeetha Vadakke-Madathil

Sangeetha Vadakke-Madathil, PhD, is currently a junior faculty (Instructor of Medicine) at Icahn School of Medicine at Mount Sinai, New York, NY. After receiving her Ph.D. degree in human hematopoietic stem cells and transplant biology from National Centre for Cell...

read more